Table 1 Demographic and clinical data of the study population.
| Total (n = 12247) | Men (n = 7179) | Women (n = 5068) | |
|---|---|---|---|
| Age (years), mean (SD) | 43.08 (13.61) | 43.36 (13.67) | 42.68 (13.57)** |
| BMI (kg/m2), mean (SD) | 23.36 (3.31) | 24.13 (3.13) | 22.29 (3.24)** |
| Sonographic fatty liver, n (%) | 2715 (22.2) | 2016 (28.1) | 699 (13.8)** |
| BMI ⩾25 kg/m2, n (%) | 3733 (30.5) | 2821 (39.3) | 912 (18.0)** |
| High fasting glucose ⩾6.1 mmol/l, n (%) | 1327 (10.8) | 861 (12) | 466 (9.2)** |
| High systolic blood pressure ⩾140 mm Hg, n(%) | 1526 (12.5) | 1034 (14.4) | 492 (9.7)** |
| High diastolic blood pressure ⩾90 mm Hg, n (%) | 1796 (14.7) | 1335 (18.6) | 461 (9.1)** |
| Alanine aminotransferase ⩾43 IU/l, n (%) | 1745 (14.2) | 1400 (19.5) | 345 (6.8)** |
| High total cholesterol ⩾5.2 mmol/l, n (%) | 3325 (27.1) | 2017 (28.1) | 1308 (25.8)* |
| High triglyceride ⩾1.7 mmol/l, n (%) | 3048 (24.9) | 2247 (31.3) | 801 (15.8)* |
BMI, body mass index.
*p<0.05, indicating significant difference between sexes.
**p<0.001, indicating significant difference between sexes.